Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 69,462 | 101,685 | 53,333 | 57,596 | 55,307 |
| Cost of Goods | 4,753 | 4,504 | 4,409 | 5,789 | 8,026 |
| Gross Profit | 64,709 | 97,181 | 48,924 | 51,807 | 47,281 |
| Operating Expenses | 37,042 | 36,582 | 36,560 | 35,941 | 33,251 |
| Operating Income | 28,420 | 61,103 | 12,773 | 16,655 | 14,056 |
| Interest Expense | 1,894 | 1,874 | 1,853 | 1,955 | 2,060 |
| Other Income | 1,094 | 753 | 591 | 522 | 425 |
| Pre-tax Income | 27,620 | 59,982 | 11,511 | 15,222 | 12,421 |
| Income Tax | -280 | 369 | 65 | N/A | N/A |
| Net Income Continuous | 27,900 | 59,613 | 11,446 | 14,341 | 12,421 |
| Net Income | $27,900 | $59,613 | $11,446 | $14,341 | $12,421 |
| EPS Basic Total Ops | 1.55 | 3.33 | 0.64 | 0.81 | 0.71 |
| EPS Basic Continuous Ops | 1.55 | 3.33 | 0.64 | 0.82 | 0.71 |
| EPS Diluted Total Ops | 1.46 | 3.28 | 0.63 | 0.82 | 0.70 |
| EPS Diluted Continuous Ops | 1.46 | 3.28 | 0.63 | 0.81 | 0.70 |
| EPS Diluted Before Non-Recurring Items | 1.46 | 3.28 | 0.63 | 0.80 | 0.70 |
| EBITDA(a) | $28,556 | $61,460 | $13,187 | $16,983 | $14,598 |